ATC code: G03XC01
As the substance is only used by women, analyses on sex or gender differences have not been considered relevant.
Raloxifene is a selective estrogen receptor modulator (SERM). The approved indication for raloxifene is treatment of osteoporosis and osteoporosis prophylaxis in postmenopausal women [1,2].
Updated: 2016-12-23
Date of litterature search: 2016-12-20
Reviewed by: Mia von Euler
Approved by: Karin Schenck-Gustafsson